Literature DB >> 18640131

Synergistic effects of multiple natural products in pancreatic cancer cells.

Zhiwei Wang1, Sita Desmoulin, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, Rohan L Deraniyagala, James Abbruzzese, Fazlul H Sarkar.   

Abstract

Pancreatic cancer (PC) remains the fourth most common cause of cancer related death in the United States. Therefore, novel strategies for the prevention and treatment are urgently needed. Numerous dietary and pharmacological agents have been proposed as alternative strategies for the prevention and/or treatment of PC. Isoflavone is a prominent flavonoid found in soy products and has been proposed to be responsible for lowering the incidence of PC in Asians. Similarly, curcumin, an active ingredient of turmeric, that inhibits growth of malignant neoplasms, has a promising role in the prevention and/or treatment of PC. Here we examined whether isoflavone together with curcumin could elicit a greater inhibition of growth of PC cells than either agent alone, and also sought to determine the molecular mechanism of action. We found that the inhibition of cell growth and induction of apoptosis was significantly greater in the combination group than that could be achieved by either agent alone. These changes were associated with decreased Notch-1 expression and DNA binding activity of NF-kappaB and its target genes such as Cyclin D1, Bcl-2, and Bcl-xL. Moreover, we found that the combination of four natural agents at lower concentration was much more effective. Collectively, our results suggest that diet containing multiple natural products should be preferable over single agents for the prevention and/or treatment of PC. The superior effects of the combinatorial treatment could partly be attributed to the inhibition of constitutive activation of Notch-1 and NF-kappaB signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640131      PMCID: PMC2536622          DOI: 10.1016/j.lfs.2008.06.017

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  33 in total

Review 1.  Using chemopreventive agents to enhance the efficacy of cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

2.  Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

Authors:  Shahar Lev-Ari; Alex Starr; Akiva Vexler; Vicki Karaush; Vered Loew; Joel Greif; Eyal Fenig; Dan Aderka; Rami Ben-Yosef
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

3.  Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells.

Authors:  Sudha Reddy; Arun K Rishi; Hu Xu; Edi Levi; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

4.  In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.

Authors:  Sanjeev Banerjee; Yuxiang Zhang; Zhiwei Wang; Mingxin Che; Paul J Chiao; James L Abbruzzese; Fazlul H Sarkar
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

Review 5.  NOTCH signaling as a novel cancer therapeutic target.

Authors:  L Miele; H Miao; B J Nickoloff
Journal:  Curr Cancer Drug Targets       Date:  2006-06       Impact factor: 3.428

6.  Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.

Authors:  Basil F El-Rayes; Shadan Ali; Ifrah F Ali; Philip A Philip; James Abbruzzese; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.

Authors:  Anupama Kotha; Madhavi Sekharam; Lucia Cilenti; Khandaker Siddiquee; Annette Khaled; Antonis S Zervos; Bradford Carter; James Turkson; Richard Jove
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

8.  Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.

Authors:  Sharmila Shankar; Ganapathy Suthakar; Rakesh K Srivastava
Journal:  Front Biosci       Date:  2007-09-01

9.  Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse.

Authors:  Guoxiang Shen; Tin Oo Khor; Rong Hu; Siwang Yu; Sujit Nair; Chi-Tang Ho; Bandaru S Reddy; Mou-Tuan Huang; Harold L Newmark; Ah-Ng Tony Kong
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

10.  Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

Authors:  Ajaikumar B Kunnumakkara; Sushovan Guha; Sunil Krishnan; Parmeswaran Diagaradjane; Juri Gelovani; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

View more
  22 in total

Review 1.  Pancreatic cancer: molecular pathogenesis and new therapeutic targets.

Authors:  Han H Wong; Nicholas R Lemoine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-09       Impact factor: 46.802

Review 2.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

3.  Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.

Authors:  Min Li; Yuqing Zhang; Uddalak Bharadwaj; Qihui Jim Zhai; Charlotte H Ahern; William E Fisher; F Charles Brunicardi; Craig D Logsdon; Changyi Chen; Qizhi Yao
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 4.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

5.  Critical need for clinical trials: an example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-alpha induced activation of NF-kappaB.

Authors:  Kristin Dominiak; Jaclyn McKinney; Lance K Heilbrun; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

6.  Soy-derived isoflavones inhibit HeLa cell growth by inducing apoptosis.

Authors:  Jun-Xia Xiao; Guo-Qing Huang; Xin Geng; Hong-Wei Qiu
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

Review 7.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

Review 8.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

9.  Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.

Authors:  Georgios Kallifatidis; Sabrina Labsch; Vanessa Rausch; Juergen Mattern; Jury Gladkich; Gerhard Moldenhauer; Markus W Büchler; Alexei V Salnikov; Ingrid Herr
Journal:  Mol Ther       Date:  2010-10-12       Impact factor: 11.454

Review 10.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.